Remdesivir, an investigational drug developed by Gilead Sciences Inc. as a general purpose anti-viral, is being billed as the most promising Covid-19 drug by researchers. Andrew Joseph is a reporter at STAT covering health and medicine who has been looking into Remdesivir, which is claimed to have aided the first confirmed U.S. coronavirus patient.
Photo: PIXABAY/
